These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 23123587)
1. Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex. Reith RM; McKenna J; Wu H; Hashmi SS; Cho SH; Dash PK; Gambello MJ Neurobiol Dis; 2013 Mar; 51():93-103. PubMed ID: 23123587 [TBL] [Abstract][Full Text] [Related]
2. Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration. Reith RM; Way S; McKenna J; Haines K; Gambello MJ Neurobiol Dis; 2011 Jul; 43(1):113-22. PubMed ID: 21419848 [TBL] [Abstract][Full Text] [Related]
4. Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin. Sundberg M; Tochitsky I; Buchholz DE; Winden K; Kujala V; Kapur K; Cataltepe D; Turner D; Han MJ; Woolf CJ; Hatten ME; Sahin M Mol Psychiatry; 2018 Nov; 23(11):2167-2183. PubMed ID: 29449635 [TBL] [Abstract][Full Text] [Related]
5. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901 [TBL] [Abstract][Full Text] [Related]
6. Tsc2 mutation rather than Tsc1 mutation dominantly causes a social deficit in a mouse model of tuberous sclerosis complex. Kashii H; Kasai S; Sato A; Hagino Y; Nishito Y; Kobayashi T; Hino O; Mizuguchi M; Ikeda K Hum Genomics; 2023 Feb; 17(1):4. PubMed ID: 36732866 [TBL] [Abstract][Full Text] [Related]
7. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Numis AL; Major P; Montenegro MA; Muzykewicz DA; Pulsifer MB; Thiele EA Neurology; 2011 Mar; 76(11):981-7. PubMed ID: 21403110 [TBL] [Abstract][Full Text] [Related]
8. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner. Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259 [TBL] [Abstract][Full Text] [Related]
9. Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features. Yuan E; Tsai PT; Greene-Colozzi E; Sahin M; Kwiatkowski DJ; Malinowska IA Hum Mol Genet; 2012 Oct; 21(19):4286-300. PubMed ID: 22752306 [TBL] [Abstract][Full Text] [Related]
10. Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin. Chévere-Torres I; Maki JM; Santini E; Klann E Neurobiol Dis; 2012 Jan; 45(1):156-64. PubMed ID: 21827857 [TBL] [Abstract][Full Text] [Related]
11. mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus. Schneider M; de Vries PJ; Schönig K; Rößner V; Waltereit R Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):455-463. PubMed ID: 27263037 [TBL] [Abstract][Full Text] [Related]
12. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Ehninger D; Han S; Shilyansky C; Zhou Y; Li W; Kwiatkowski DJ; Ramesh V; Silva AJ Nat Med; 2008 Aug; 14(8):843-8. PubMed ID: 18568033 [TBL] [Abstract][Full Text] [Related]
13. Epilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in rats. Waltereit R; Japs B; Schneider M; de Vries PJ; Bartsch D Behav Genet; 2011 May; 41(3):364-72. PubMed ID: 20927644 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of anxiety-related behaviors in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis. Ehninger D; Silva AJ Behav Genet; 2011 May; 41(3):357-63. PubMed ID: 20882401 [TBL] [Abstract][Full Text] [Related]
16. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308 [TBL] [Abstract][Full Text] [Related]
17. Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism. Young DM; Schenk AK; Yang SB; Jan YN; Jan LY Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11074-9. PubMed ID: 20534473 [TBL] [Abstract][Full Text] [Related]
18. Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation. Hwang SK; Lee JH; Yang JE; Lim CS; Lee JA; Lee YS; Lee K; Kaang BK Mol Brain; 2016 May; 9(1):56. PubMed ID: 27216612 [TBL] [Abstract][Full Text] [Related]
19. Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Way SW; McKenna J; Mietzsch U; Reith RM; Wu HC; Gambello MJ Hum Mol Genet; 2009 Apr; 18(7):1252-65. PubMed ID: 19150975 [TBL] [Abstract][Full Text] [Related]
20. Sex-Selective Effects on Behavior in a Mouse Model of Tuberous Sclerosis Complex. Saré RM; Lemons A; Figueroa C; Song A; Levine M; Beebe Smith C eNeuro; 2020; 7(2):. PubMed ID: 32303566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]